These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 12109853
1. Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation. Rizzatti EG, Garcia AB, Portieres FL, Silva DE, Martins SL, Falcão RP. Am J Clin Pathol; 2002 Jul; 118(1):31-7. PubMed ID: 12109853 [Abstract] [Full Text] [Related]
2. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement. Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP. Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596 [Abstract] [Full Text] [Related]
3. [Expressions of CD117 and CD11b in patients with APL at diagnosis and post-treatment]. Shen HQ, Tang YM, Song H, Shi SW, Yang SL, Xu WQ, Qian BQ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):644-8. PubMed ID: 16928291 [Abstract] [Full Text] [Related]
4. Spontaneous resolution of RARalpha rearrangement in bone marrow recovery with a predominance of CD117- and CD11B-negative promyelocytes. Veillon DM, Nordberg ML, Neupane P, Cotelingam JD. Am J Clin Pathol; 2002 Dec; 118(6):965; author reply 966. PubMed ID: 12472288 [No Abstract] [Full Text] [Related]
5. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping. Gorczyca W. Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601 [Abstract] [Full Text] [Related]
6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group. Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165 [Abstract] [Full Text] [Related]
7. [Effect of antisense oligodeoxynucleotide (ASODN) to PML-RAR alpha fusion gene on acute promyelocytic leukemia cell line NB4]. Yu W, Sun B, Chen Z. Zhonghua Xue Ye Xue Za Zhi; 1998 May; 19(5):227-30. PubMed ID: 11243116 [Abstract] [Full Text] [Related]
8. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, Glassman AB, Bueso-Ramos C, Huh YO. Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045 [Abstract] [Full Text] [Related]
9. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia. Oelschlaegel U, Mohr B, Schaich M, Schäkel U, Kroschinsky F, Illmer T, Ehninger G, Thiede C. Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801 [Abstract] [Full Text] [Related]
10. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L. Leukemia; 1994 Nov; 8(11):1900-5. PubMed ID: 7967734 [Abstract] [Full Text] [Related]
11. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L. Leukemia; 1994 Nov; 8 Suppl 2():S71-6. PubMed ID: 7815843 [Abstract] [Full Text] [Related]
12. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [Abstract] [Full Text] [Related]
13. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia. Auewarakul CU, Lauhakirti D, Promsuwicha O, Munkhetvit C. Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053 [Abstract] [Full Text] [Related]
14. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia]. Shi H, Zhu F, Xiao AQ, Zhang ZR, Zhang R. Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777 [Abstract] [Full Text] [Related]
15. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model. Santana BA, Pintão MC, Abreu e Lima RS, Scheucher PS, Santos GA, Garcia AB, Falcão RP, Rego EM. Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899 [Abstract] [Full Text] [Related]
16. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602 [Abstract] [Full Text] [Related]
17. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia. Mosleh M, Mehrpouri M, Ghaffari S, Saei Z, Agaeipoor M, Jadali F, Satlsar ES, Gholampour R. Scand J Clin Lab Invest; 2020 Jul; 80(2):87-92. PubMed ID: 31829759 [Abstract] [Full Text] [Related]
18. Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium. Tirado CA, Chen W, Valdez F, Karandikar N, Arbini A, Acevedo I, Garcia R, Davila O, Smart RL, Matthews E, Kirk A, Collins RH. Cancer Genet Cytogenet; 2010 Jul 01; 200(1):47-53. PubMed ID: 20513534 [Abstract] [Full Text] [Related]
19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 Jul 01; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]